SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-171145
Filing Date
2023-06-21
Accepted
2023-06-21 16:05:56
Documents
12
Period of Report
2023-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d453914d8k.htm   iXBRL 8-K 30784
  Complete submission text file 0001193125-23-171145.txt   152856

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prld-20230616.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20230616_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20230616_pre.xml EX-101.PRE 11254
6 EXTRACTED XBRL INSTANCE DOCUMENT d453914d8k_htm.xml XML 3399
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 231029863
SIC: 2834 Pharmaceutical Preparations